--- a
+++ b/clusters/9knumclustersv2/clust_1012.txt
@@ -0,0 +1,76 @@
+Unstable angina.
+Unstable angina pectoris </= months prior to enrollment
+Patients with known unstable angina pectoris
+Unstable angina within  months prior to study entry,
+Unstable cardiac disease, including unstable angina or unstable hypertension, or need to change medication within  weeks of provision of consent due to lack of disease control
+Angina pectoris,
+Unstable angina pectoris,
+Unstable angina pectoris
+Significant cardiovascular disease, within  months prior to randomisation, unstable arrhythmias, or unstable angina
+Unstable angina pectoris
+Unstable angina pectoris or cardiac ventricular arrhythmia.
+Unstable cardiac disease, including unstable angina or unstable hypertension, as defined by the need for change in medication for lack of disease control within the last three months
+Symptomatic ischemia, unstable angina pectoris
+Severe/unstable angina
+Unstable angina
+Unstable angina pectoris <  months prior to screening
+Unstable angina within  months prior to first dose;
+Unstable angina within  months prior to study entry
+Unstable angina or new-onset angina
+Unstable angina pectoris on medication
+Current unstable angina.
+Uncontrolled or significant heart disorder such as unstable angina
+Subjects with a known unstable or uncontrolled angina pectoris.
+Subjects with known unstable or uncontrolled angina pectoris.
+Patients with known unstable or uncontrolled angina pectoris
+Unstable angina pectoris
+Unstable angina or angina requiring surgical or medical intervention; and/or
+unstable angina (angina symptoms at rest) within less than or equal to  months prior to randomization; and
+No unstable angina pectoris <  months
+Unstable angina or angina requiring surgical or medical intervention; and/or
+Unstable angina.
+Significant cardiac arrhythmia or unstable angina or angina requiring surgical or medical intervention; and/or
+Unstable angina within the last  months prior to registration
+Unstable angina pectoris
+Angina pectoris requiring antianginal medication
+Unstable angina pectoris
+Unstable angina within  months prior to first dose
+Subjects with known unstable or uncontrolled angina pectoris.
+Unstable angina
+Patients with unstable angina or serious arrhythmia
+Subjects with known unstable or uncontrolled angina pectoris.
+No currently unstable angina and/or uncontrolled cardiac arrhythmias
+Angina pectoris requiring treatment
+History of unstable angina within  year prior to study entry
+Unstable angina
+Unstable angina
+Grade >=  heart failure or history of unstable angina
+Angina pectoris requiring antianginal medications
+Unstable angina
+Unstable angina pectoris ? months prior to study participation
+Unstable angina
+Unstable angina
+Unstable angina
+Unstable angina pectoris
+Unstable angina pectoris.
+Unstable angina pectoris or cardiac arrhythmia
+Known unstable or uncontrolled angina pectoris
+Angina pectoris requiring therapy
+Unstable angina pectoris or cardiac arrhythmia;
+Angina pectoris requiring therapy
+Unstable angina pectoris
+Unstable angina defined as angina (or anginal equivalent)  or more times per week despite medical therapy.
+Unstable angina pectoris on medication
+Unstable angina
+Unstable cardiac disease, including unstable angina or unstable hypertension, as defined by the need for change in medication for lack of disease control within the last three months
+If they have angina or unstable coronary disease
+Have unstable angina
+Angina
+Unstable angina or angina requiring surgical or medical intervention; and/or
+unstable angina,
+Unstable angina
+Unstable angina
+Unstable angina
+Patients with unstable occlusive disease (eg, crescendo angina)
+History of unstable angina within  year of study entry
+Unstable angina